Investigating the effects of zinc in reducing the risk of diabetes and cardiovascular diseases
Phase 3
Recruiting
- Conditions
- Metabolic syndrome.Metabolic syndromeE88.81
- Registration Number
- IRCT20240125060804N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age over 18 to 70 years old
Definite diagnosis of metabolic syndrome based on clinical symptoms and laboratory findings.
Overweight or obesity (BMI above 25)
Obtaining written informed consent from patients
Exclusion Criteria
Taking zinc supplements at least three months before starting the study
The need to take blood sugar and lipid lowering drugs according to the doctor's opinion
History of other diseases related to oxidative stress and inflammation such as cardiovascular diseases, autoimmune diseases, types of diabetes, IBD, asthma, cancer, kidney and liver diseases, Infectious diseases
Smoking and alcohol consumption
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method